Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type 1 DM and Diabetic Nephropathy
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The primary objective is to assess the impact of three months of treatment with an active
vitamin D analogue on a risk marker for excess overall mortality and cardiovascular
morbidity/mortality in Type 1 diabetic patients with diabetic kidney disease. The hypothesis
is that active vitamin D analogue treatment reduces the risk of cardiovascular morbidity and
mortality in patients with type 1 diabetic kidney disease.